Stockreport

Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]

Century Therapeutics, Inc.  (IPSC) 
PDF This compares to loss of $0.56 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 24%. [Read more]